tradingkey.logo

Metavia Presents Pre-Clinical Data On Da-1241 Demonstrating Additive Hepatoprotective Effects In Combination With Efruxifermin At The ADA's 85Th Scientific Session

ReutersJun 21, 2025 1:14 PM

- MetaVia Inc MTVA.O:

  • METAVIA PRESENTS PRE-CLINICAL DATA ON DA-1241 DEMONSTRATING ADDITIVE HEPATOPROTECTIVE EFFECTS IN COMBINATION WITH EFRUXIFERMIN AT THE ADA'S 85TH SCIENTIFIC SESSION

  • METAVIA INC - COMBINATION THERAPY DECREASES INFLAMMATORY AND FIBROTIC GENE EXPRESSION

  • METAVIA INC - COMBINATION THERAPY REDUCES INFLAMMATORY AND FIBROTIC PROTEINS IN THE LIVER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI